|
Office of Biotechnology Activities
|
National Institutes of Health - Office of Science Policy
|
| |
| Recombinant DNA Advisory Committee Meetings |
|
 |
|
|
|
|
|
|
|
|
|
| |
 |
Scheduled meetings for 2009
|
|
|
| |
|
Scheduled meetings for 2010
|
|
|
| |
|
Live Webcast of Current Meeting (Available when a meeting is in progress) |
|
|
| |
|
Workshops, Safety Symposia, and Safety and Policy Conferences |
|
|
| |
|
Past meetings - Browse webcasts for publicly reviewed protocols |
|
|
| |
|
Past meetings - Browse by date (2000 to present) |
|
|
| |
|
Past meetings - Browse by date (1990 to 1999) |
|
|
| |
|
Federal Register Notices (since 1994) |
|
| |
|
|
|
|
2009 RAC Meetings
|
|
|
| |
The planned meetings and protocol submission deadlines for Public Recombinant DNA Advisory Committee (RAC) Review* for 2009 are shown below.
|
|
| |
|
| |
|
December 1-2, 2009, RAC -- NIH Main Campus, Natcher, Rm. E1&E2, Bethesda, MD
|
|
|
| |
 |
Agenda |
|
|
| |
|
Deadline for protocol submission: October 6, 2009 |
|
|
| |
As required under Section III-A-1 of the NIH Guidelines, the NIH RAC will be discussing an experiment proposed by Dr. Harlan Caldwell at the Rocky Mountain Laboratories involving the deliberate transfer of tetracycline resistance to Chlamydia trachomatis. For additional information, please click here. |
|
Top of Page |
|
|
|
|
2010 RAC Meetings
|
|
|
| |
The planned meetings and protocol submission deadlines for Public Recombinant DNA Advisory Committee (RAC) Review* for 2009 are shown below.
|
|
| |
|
| |
|
March 9-11, 2010, RAC -- NIH Main Campus, Bldg. 31, Floor 6C, Rm. 6, Bethesda, MD
|
|
| |
|
| |
|
June 7-9, 2010, RAC -- NIH Main Campus, Bldg. 31, Floor 6C, Rm. 6, Bethesda, MD
|
|
| |
|
| |
|
September 16-17, 2010, RAC -- NIH Main Campus, Bldg. 31, Floor 6C, Rm. 6, Bethesda, MD
|
|
| |
|
| |
|
December 6-8, 2010, RAC -- NIH Main Campus, Bldg. 31, Floor 6C, Rm. 6, Bethesda, MD
|
|
Top of Page |
|
|
|
| |
Note: |
NIH/OBA will accept submission material at any time. However, if a protocol is submitted less than eight weeks before a scheduled RAC meeting and subsequently is recommended for public discussion by the full RAC, the public discussion of that protocol will be deferred until the next scheduled RAC meeting. This eight-week period is needed to ensure adequate time for review by the committee members.
|
|
|
|
|
|
|
|
|